Quec.li

everything quec.li

Merck loses bid to revive $2.54 billion patent verdict against Gilead

[Reuters: Company News] Merck loses bid to revive $2.54 billion patent verdict against Gilead: A U.S. appeals court on Wednesday dealt a
major blow to Merck & Co Inc as it upheld a ruling that
threw out a $2.54 billion jury verdict the drugmaker had won
against Gilead Sciences Inc.



    Return home.